Lumida
/WTM
⌘K
White Mountains Insurance Group Ltd

White Mountains Insurance Group Ltd

WTM
$2,211.52USD+0.68%+15.04 today

MARKET CAP

5.5B

P/E (TTM)

27.7x

FWD P/E

27.7x

DAY RANGE

$2,198 – $2,240

52W RANGE

$1,648
$2,333

The case for & against

Bull & Bear analysis

Bullish

White Mountains Insurance Group Ltd. (NYSE: WTM) is a diversified global insurance holding company primarily engaged in providing reinsurance, insurance, and insurance-related services. As the parent company of Kudu Investment Management, WTM is strategically positioned to catalyze growth in the insurance sector through innovative investments and partnerships. With a focus on premium-capture strategies and operational excellence, WTM is poised to take advantage of the evolving landscape of the insurance industry, which is influenced by emerging technologies and shifting consumer preferences.

Bull says

  • High earnings yield and strong book-to-price signal undervaluation.
  • Guidance of $90–100 M free cash flow indicates robust cash generation.
  • Kudu’s stakes in Australian Financial Planning Group expand adviser reach.
  • Upward analyst revisions reflect improving earnings expectations.
  • Low share price volatility supports confidence in turbulent markets.
  • Low leverage risk highlights balance sheet resilience during cycles.

Bear says

  • Negative growth factor warns of potential revenue stagnation.
  • Weak dividend yield limits appeal to income-focused investors.
  • Small market cap restricts scale; stock down 8.5% over 10 days.
  • Minimal institutional holdings (13F ~5%) signal investor skepticism.
  • Competitive pricing pressures may squeeze P&C segment margins.
  • DCF analysis flags shares as potentially expensive despite low P/E.

Investment themes with WTM

L&H Insurance +0.32%

PGR · TRV · ALL

Earnings Call · Q4 2025 · Mgmt. Guidance

Updated 07-05-2026neutral

Transcript signals

Bull points

  • 2025 was a record year. We crossed several significant milestones: $2 billion of transaction value, $1 billion of revenue, and $100 million of adjusted EBITDA, all for the first time.
  • We expect take rates in Q1 to be above Q4 levels.
  • $99 million of free cash flow.

Bear points

  • our health vertical declined 40%.
  • $291 million, down 3% year-over-year as reported, but up 9% excluding under 65 health.
  • Under 65 Health contributed approximately $7 million of revenue in 2025, down from $41 million in 2024.
Read full transcript analysis ›